[
  {
    "ts": "2026-02-23T01:53:17+00:00",
    "headline": "Bank of America (BAC) Strengthens Private Credit Platform with $25B Deployment",
    "summary": "Bank of America Corporation (NYSE:BAC) is included among the 14 Best Warren Buffett Dividend Stocks to Buy. On February 20, Bloomberg reported that Bank of America Corporation (NYSE:BAC) is committing $25 billion to private-credit deals. The move puts the bank alongside other Wall Street firms that are using their own balance sheets to expand in […]",
    "url": "https://finance.yahoo.com/news/bank-america-bac-strengthens-private-015317169.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "eecef2ca-f8b6-318d-96b4-436f2c49d3a8",
      "content": {
        "id": "eecef2ca-f8b6-318d-96b4-436f2c49d3a8",
        "contentType": "STORY",
        "title": "Bank of America (BAC) Strengthens Private Credit Platform with $25B Deployment",
        "description": "",
        "summary": "Bank of America Corporation (NYSE:BAC) is included among the 14 Best Warren Buffett Dividend Stocks to Buy. On February 20, Bloomberg reported that Bank of America Corporation (NYSE:BAC) is committing $25 billion to private-credit deals. The move puts the bank alongside other Wall Street firms that are using their own balance sheets to expand in […]",
        "pubDate": "2026-02-23T01:53:17Z",
        "displayTime": "2026-02-23T01:53:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/bb57be1f02e9d86cecf6ffb73cf20353",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Bank of America (BAC) Strengthens Private Credit Platform with $25B Deployment",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/n24KM0HPWdC0tHmxXY2JAQ--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/bb57be1f02e9d86cecf6ffb73cf20353.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TEXjk6sl95bnJjvI62Mzyw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/bb57be1f02e9d86cecf6ffb73cf20353.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bank-america-bac-strengthens-private-015317169.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bank-america-bac-strengthens-private-015317169.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T00:20:28+00:00",
    "headline": "How The Viper Energy (VNOM) Narrative Is Evolving With Mixed Analyst Valuation Tweaks",
    "summary": "Viper Energy’s fair value estimate has shifted only slightly, from US$50.11 to US$50.22, keeping the headline price target effectively in the same ballpark. That small move sits against a mixed research backdrop, with one bank lifting its target by US$3 while others trimmed theirs by US$1 and US$6, reflecting a tighter debate around how much is already priced in. As you read on, you will see how these tweaks fit into the broader story and what to watch as the narrative continues to...",
    "url": "https://finance.yahoo.com/news/viper-energy-vnom-narrative-evolving-002028076.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "3791828d-cb3a-387a-aaca-a2dd67825fa3",
      "content": {
        "id": "3791828d-cb3a-387a-aaca-a2dd67825fa3",
        "contentType": "STORY",
        "title": "How The Viper Energy (VNOM) Narrative Is Evolving With Mixed Analyst Valuation Tweaks",
        "description": "",
        "summary": "Viper Energy’s fair value estimate has shifted only slightly, from US$50.11 to US$50.22, keeping the headline price target effectively in the same ballpark. That small move sits against a mixed research backdrop, with one bank lifting its target by US$3 while others trimmed theirs by US$1 and US$6, reflecting a tighter debate around how much is already priced in. As you read on, you will see how these tweaks fit into the broader story and what to watch as the narrative continues to...",
        "pubDate": "2026-02-23T00:20:28Z",
        "displayTime": "2026-02-23T00:20:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/fef15a04bcb8e7f05d317d73670619f7",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bccsBC98ceWiSbvG7ke88w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fef15a04bcb8e7f05d317d73670619f7.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dWw_CBHM0zJA0F.CumGaPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/fef15a04bcb8e7f05d317d73670619f7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/viper-energy-vnom-narrative-evolving-002028076.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/viper-energy-vnom-narrative-evolving-002028076.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VNOM"
            },
            {
              "symbol": "BAC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T06:07:15+00:00",
    "headline": "How Sephience Is Reshaping The Story For PTC Therapeutics (PTCT) And Analyst Expectations",
    "summary": "Analysts have adjusted their fair value estimate for PTC Therapeutics slightly lower, from US$88.50 to about US$87.93, keeping price targets clustered in the low to mid US$80s. This small move reflects how recent Street research is balancing optimism around Sephience with caution on DMD pressure and longer term growth visibility. As you read on, you will see how these shifting targets and narratives might shape how you follow PTC from here. Stay updated as the Fair Value for PTC Therapeutics...",
    "url": "https://finance.yahoo.com/news/sephience-reshaping-story-ptc-therapeutics-060715713.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "cae2212f-04ef-310d-b6f7-a76157eb4f19",
      "content": {
        "id": "cae2212f-04ef-310d-b6f7-a76157eb4f19",
        "contentType": "STORY",
        "title": "How Sephience Is Reshaping The Story For PTC Therapeutics (PTCT) And Analyst Expectations",
        "description": "",
        "summary": "Analysts have adjusted their fair value estimate for PTC Therapeutics slightly lower, from US$88.50 to about US$87.93, keeping price targets clustered in the low to mid US$80s. This small move reflects how recent Street research is balancing optimism around Sephience with caution on DMD pressure and longer term growth visibility. As you read on, you will see how these shifting targets and narratives might shape how you follow PTC from here. Stay updated as the Fair Value for PTC Therapeutics...",
        "pubDate": "2026-02-23T06:07:15Z",
        "displayTime": "2026-02-23T06:07:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/I2k3PKJsWIEX9xgEQz8JwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tmSjpFKmBAT61w1lG5.BLQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sephience-reshaping-story-ptc-therapeutics-060715713.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sephience-reshaping-story-ptc-therapeutics-060715713.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PTCT"
            },
            {
              "symbol": "PTC"
            },
            {
              "symbol": "BAC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]